Overview

SPG Blocks for Headaches

Status:
Recruiting

Trial end date:
2021-06-01

Target enrollment:

Participant gender:

Summary

This will be a single-center, open-label clinical trial comparing sphenopalatine ganglion blocks to standard intravenous therapy for patients who come to the emergency department for a headache.

Phase:

Phase 4

Details

Lead Sponsor:

Kendall Healthcare Group, Ltd.

Collaborator:

Nova Southeastern University

Treatments:

Prochlorperazine